References
- Gafni A, Birch S. Incremental cost-effectiveness ratios (ICER): The silence of the lambda. Soc Sci Med. 2006; 62: 2091–100. [PubMed Abstract].
- Gold MR, Siegel JE, Russel LB, Weinstein MC. Cost-effectiveness in health and medicine. 1996; New York: Oxford University Press.
- National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal 2013. 2013. Available from: http://www.nice.org.uk/media/D45/1E/GuideToMethodsTechnologyAppraisal2013.pdf [cited 21 August 2013].
- Weinstein MC, Stason WB. Foundation of cost effectiveness analysis for health and medical practices. N Engl J Med. 1977; 296: 716–21. [PubMed Abstract].
- McDonald H. Appraising Canada's Joint/Pan-Canadian Oncology Drug Review (JODR/pCODR) using an economic perspective. Hamilton, ON: 2013. Available from: http://hdl.handle.net/11375/13949 [cited 14 February 2016]..
- Wagstaff A. QALYs and the equity-efficiency trade-off. J Health Econ. 1991; 10(1): 21–41. [PubMed Abstract].
- National Institute for Health and Care Excellence (n.d.). 2011/12 Review of the guide to the methods of technology appraisal. Available from: http://www.nice.org.uk/aboutnice/howwework/devnicetech/technologyappraisalprocessguides/GuideToMethodsTA201112.jsp [cited 31 August 2012]..
- Chafe R, Culyer A, Dobrow M, Coyte P, Sawka C, O'Reilly S, etal. Access to cancer drugs in Canada: Looking beyond coverage decisions. Healthc Policy. 2011; 6(3): 27–35. [PubMed Abstract] [PubMed CentralFull Text].
- Birch S, Gafni A. Economics and the evaluation of health care programmes: Generalizability of methods and implications for generalizability of results. Health Policy. 2003; 64: 207–19. [PubMed Abstract].
- Natarajan MK, Gafni A, Yusuf A. Determining optimal population rates of cardiac catheterization: A phantom alternative?. CMAJ. 2005; 173(1): 49–52. [PubMed Abstract] [PubMed CentralFull Text].
- Canadian Cancer Society's Advisory Committee on Cancer Statistics . Canadian Cancer Statistics 2015. 2015; Toronto, ON: Canadian Cancer Society.
- Government of Ontario. Expenditure estimates for the Ministry of Health and Long Term Care (2016–17). 2016. Available from: https://www.ontario.ca/page/expenditure-estimates-ministry-community-and-social-services-2016-17#vote2; https://www.ontario.ca/page/expenditure-estimates-ministry-health-and-long-term-care-2016-17#section-4 [cited 18 May 2016].
- Finances Québec. The Québec economic plan. 2015. Available from: http://www.budget.finances.gouv.qc.ca/budget/2015-2016/en/documents/BudgetPlan.pdf [cited 18 May 2016]..
- Alberta Treasury Board and Finance. 2016–17 Government estimates. 2016. Available from: http://finance.alberta.ca/publications/budget/budget2016/index.html#estimates [cited 18 May 2016]..
- Cancer Care Ontario. Backgrounder: Cancer drug funding decision-making processes in Ontario. 2012; Private Communication.
- Statistics Canada. Population and dwelling counts, for Canada, provinces and territories, 2011 and 2006 censuses. 2011. Available from: http://www12.statcan.gc.ca/census-recensement/2011/dp-pd/hlt-fst/pd-pl/Table-cfm?LANG=Eng&T=101&SR=1&S=3&O=D [cited 31 August 2012]..
- Koester O. P/T Oncology collaborative initiative (Joint Oncology Drug Review), Canadian Association for Healthcare Reimbursement Meeting. 2008. Available from: http://www.cahrp.ca/resources/WRM-OlafKoester.pdf [cited 21 June 2010].
- Pan-Canadian Oncology Drug Review (n.d.). Frequently asked questions. Available from: http://www.pcodr.ca/wcpc/portal/Home/General_PC/FAQs?_afrLoop=299555791299000&_afrWindowMode=0&_adf.ctrl-state=15sfep90t5_91#q9 [cited 21 August 2013].
- National Institute for Health and Clinical Excellence (n.d.). About NICE: What we do. Available from: http://www.nice.org.uk/aboutnice/whatwedo/what_we_do.jsp [cited 15 December 2012].